Chonluten 20 mg

Chonluten is a short synthetic tripeptide bioregulator studied for its role in inflammation-related signaling, epithelial tissue regulation, and cellular adaptive responses. Research interest in Chonluten focuses on how small peptides derived from bronchial-associated tissues may influence immune modulation, cell proliferation, and tissue repair processes in controlled laboratory models.

Rather than acting through a single pathway, Chonluten is investigated for its regulatory effects on cytokine signaling, oxidative balance, and cellular communication within epithelial and connective tissue environments. These properties make it relevant to experimental research involving inflammatory balance, respiratory tissue models, and cellular resilience.

Current research with Chonluten covers bronchial inflammatory signaling, cytokine-mediated epithelial responses, and the regulatory biology of short peptide-derived sequences in pulmonary tissue. Experimental work has linked Glu-Asp-Gly-class tripeptides to modulation of inflammatory and proliferative pathways in epithelial cell models, supporting continued investigation of Chonluten in studies of lung tissue homeostasis and respiratory mucosal regulation (Ivanova et al., 2015 — Bulletin of Experimental Biology and Medicine; Avolio et al., 2022 — International Journal of Molecular Sciences).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.